-+ 0.00%
-+ 0.00%
-+ 0.00%

Vector Science & Therapeutics announces investor Q&A meeting

PUBT·07/24/2026 22:38:35
Listen to the news
Vector Science & Therapeutics announces investor Q&A meeting
  • Vector Science & Therapeutics will hold an investor Q&A meeting in Mequon, Wisconsin on July 28, 2026.
  • Discussion is expected to cover first quarterly financial results since the April 2026 reverse takeover.
  • Updates are also expected on the peptide manufacturing ramp, with first revenue targeted for August 2026.
  • The meeting is set to address progress toward an FDA 510(k) submission for VectorMist, with potential revenue before end-2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vector Science and Therapeutics Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202607241837PR_NEWS_USPR_____LA12105) on July 24, 2026, and is solely responsible for the information contained therein.